Checchi Capital Advisers, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Checchi Capital Advisers, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$249,423
+9.6%
16,123
+11.3%
0.02%
+15.0%
Q2 2023$227,638
+0.6%
14,490
+5.5%
0.02%
-9.1%
Q1 2023$226,303
+5.3%
13,732
-0.3%
0.02%0.0%
Q4 2022$214,859
+19.4%
13,773
-1.0%
0.02%
+29.4%
Q3 2022$180,000
-8.2%
13,909
+3.7%
0.02%0.0%
Q2 2022$196,000
+5.4%
13,414
+3.4%
0.02%
+6.2%
Q1 2022$186,000
+19.2%
12,967
+13.3%
0.02%
+14.3%
Q4 2021$156,000
-44.1%
11,449
-32.9%
0.01%
-50.0%
Q3 2021$279,000
-2.8%
17,063
+0.2%
0.03%0.0%
Q2 2021$287,000
-9.2%
17,037
-1.6%
0.03%
-9.7%
Q1 2021$316,000
+0.3%
17,322
+0.1%
0.03%
-3.1%
Q4 2020$315,000
-12.0%
17,309
-13.6%
0.03%
-20.0%
Q3 2020$358,000
-3.0%
20,042
-2.6%
0.04%
-9.1%
Q2 2020$369,000
+23.8%
20,579
+4.8%
0.04%
+51.7%
Q1 2020$298,000
-18.1%
19,642
+6.4%
0.03%
-40.8%
Q4 2019$364,000
+46.2%
18,467
+27.6%
0.05%
+53.1%
Q3 2019$249,000
+0.8%
14,477
+3.9%
0.03%
+3.2%
Q2 2019$247,000
-25.4%
13,930
-14.2%
0.03%
-20.5%
Q1 2019$331,00016,2320.04%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2020
NameSharesValueWeighting ↓
Glenview Capital Management 16,104,222$294,063,0004.98%
GMT CAPITAL CORP 2,468,695$45,078,0003.31%
MANAGED ASSET PORTFOLIOS, LLC 1,065,756$19,461,0003.13%
Blackcrane Capital, LLC 14,571$1,723,0002.72%
BFAM Partners (Cayman) Ltd 328,690$6,002,0002.36%
Paulson & Co. 4,727,415$86,323,0001.98%
Mondrian Investment Partners LTD 3,510,404$59,677,0001.28%
Lumbard & Kellner, LLC 135,550$2,264,0000.80%
DAVIDSON INVESTMENT ADVISORS 500,203$9,134,0000.78%
TFG Asset Management GP Ltd 589,390$10,762,0000.77%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders